South Korea's Lotte Group held a completion ceremony on Wednesday (November 18) for its first biopharmaceutical manufacturing plant in Songdo, Incheon, as part of efforts to diversify its business beyond traditional retail, food, and chemicals. Lotte Group Chairman Shin Dong-bin stated at the ceremony that the biopharmaceutical business is a future growth engine for the group and will spearhead South Korea's next-generation industry.